We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Vaccine Design and Testing – Products

Product News

BiondVax Announces Positive Phase IIa Results for Universal Flu Vaccine

BiondVax’s Multimeric-001 Universal Influenza Vaccine successfully meets primary and secondary endpoints with strong safety and immunogenicity data in 200 participants.
Product News

BiondVax Announces Positive Phase IIa Results for Universal Flu Vaccine

BiondVax’s Multimeric-001 Universal Influenza Vaccine successfully meets primary and secondary endpoints with strong safety and immunogenicity data in 200 participants.
Product News

Pharmanet Collaborates with the Cancer Immunotherapy Trials Network

PharmaNet collaborate with CITN to help identify trials with immunotherapy agents prioritized by the CITN as having high potential for cancer therapy.
Product News

454 Sequencing Systems Aid in Discovery of Novel Canine Hepatitis C Virus

Researchers report the use of high-throughput sequencing technology to identify a novel hepatitis C virus in domestic dogs.
Product News

AnaSpec Introduces Dipeptide Library

Dipeptide and tripeptide libraries can be systematically constructed to contain almost all possible combinations of the 20 common amino acids.
Product News

Immunotope and Immunovaccine Announce U.S. Patent for Therapeutic Cancer Vaccine Antigens

U.S. patent and trademark office has issued an official notice of allowance for a new U.S. patent specific to the DPX-0907 therapeutic cancer vaccine.
Product News

Dynavax Reports Additional Positive Phase 1B Immunogenicity Data for Hepatitis B Therapy Candidate

The data for DV-601 has reported in a poster session Saturday, February 19 at the 21st Conference of the APASL 2011 in Bangkok, Thailand.
Product News

Synexus Support Vaccines Trials with Dedicated Team

Company has created vaccines team to help pharma and biotech companies find the thousands of patients they need for their late phase trials.
Product News

GE Healthcare Launches Biacore T200 for Characterization of Biomolecular Interactions

Versatile label-free system for use from early research through to drug discovery and development, and QC.
Advertisement